retatrutide phase 2 weight loss is generating a lot of buzz in the medical world—and for good reason. As research continues, many experts believe it could represent the next generation of metabolic health treatments The most intensive medical obesity

While clinical trials show adults on the highest dose of Zepbound lose an average of 22.5% of their body weight after 72 weeks (when paired with diet and exercise), recent Phase 3 trial data (from the TRIUMPH-1 study released in May 2026) shows even better results

Impact of global mean normalization on regional glucose metabolism in the human brain

In the first round of X!Tandem searching, the database search was conducted against a custom microbial database (407,878 entries) comprising protein sequences from Bacteria, Virus, Archaea, and fungus

Research from the New England Journal of Medicine has shown that combining semaglutide with structured resistance training significantly reduces lean mass loss compared to medication alone

Wearing damp panty liners all day can also lead to yeast infections, so its important to change them more often